Local control after tailored surgical treatment of early cervical cancer

International Journal of Gynecological Cancer

Volumn 21, Issue 4, 2011, Pages 690-698

  Cibula, David ^a   Pinkavova, Ivana ^a   Dusek, Ladislav ^b   Slama, Jiri ^a   Zikan, Michael ^a   Fischerova, Daniela ^a   Freitag, Pavel ^a   Dundr, Pavel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Cervical cancer; Local control; Radical hysterectomy; Surgical treatment; Survival

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; OBSTETRIC OPERATION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 80051911823     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318213653d     Document Type: Article

References (27)

1. Suprasert P, Srisomboon J, Kasamatsu T. Radical hysterectomy for stage IIB cervical cancer: a review. Int J Gynecol Cancer. 2005;15:995-1001. (Pubitemid 43110147)
2. Ditto A, Martinelli F, Hanozet F, et al. Class III NSRH: oncological outcome in 170 cervical cancer patients. Gynecol Oncol. 2010;119:192-197.
3. Pluta M, Rob L, Charvat M. Less radical surgery than radical hysterectomy in early stage cervical cancer: a pilot study. Gynecol Oncol. 2009;113:181-184.
4. Fotiou S, Tserkezoglou A, Hatzieleftheriou G, et al. Class III vs class II radical hysterectomy in stage IB cervical carcinoma: a comparison of morbidity and survival. Int J Gynecol Cancer. 1997;7:117-121. (Pubitemid 27237398)
5. Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3-12. (Pubitemid 32062080)
6. Höckel M, Horn LC, Braumann UD, et al. Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol. 2009;10:683-692.
7. Fischerova D, Cibula D, Stenhova H, et al. Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. Int J Gynecol Cancer. 2008;18:766-772. (Pubitemid 352020161)
8. Hawnaur JM, Johnson RJ, Carrington BM, et al. Predictive value of clinical examination, transrectal ultrasound and magnetic resonance imaging prior radiotherapy in carcinoma of the cervix. Br J Radiol. 1998;71:819-827. (Pubitemid 28391081)
9. Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9:297-303. (Pubitemid 351722949)
10. Cibula D, Abu-Rustum NR. Pelvic lymphadenectomy in cervical cancerVsurgical anatomy and proposal for a new classification system. Gynecol Oncol. 2010;116:33-37.
11. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36. (Pubitemid 12142173)
12. Inoue T. Prognostic significance of the depth of invasion relating to nodal metastases, parametrial extension, and cell types. A study of 628 cases with Stage IB, IIA, and IIB cervical carcinoma. Cancer. 1984;54:3035-3042. (Pubitemid 15184090)
13. Samlal RA, van der Velden J, Ten Kate FJ, et al. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer. 1997;80:1234-1240. (Pubitemid 27407223)
14. Kinney WK, Hodge DO, Egorshin EV, et al. Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. Gynecol Oncol. 1995;57:3-6.
15. Burghardt E, Baltzer J, Tulusan H, et al. Results of surgical treatment of 1028 cervical cancers studied volumetry. Cancer. 1992;70:648-655.
16. Fujii S, Takakura K, Matsumura N, et al. Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy. Gynecol Oncol. 2007;107:4-13. (Pubitemid 47464555)
17. Raspaliesi F, Ditto A, Fontanelli R, et al. Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic nerve. Gynecol Oncol. 2004;93:307-314. (Pubitemid 38507594)
18. Shimada M, Kigawa J, Takahashi M, et al. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer. Gynecol Oncol. 2004;93:628-631. (Pubitemid 38766046)
19. Eddy GL, Bundy BN, Creasman WT, et al. Treatment of (bulky) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: A phase III trial of the gynecologic oncology group. Gynecol Oncol. 2007;106: 362-369 (Pubitemid 47087936)
20. dos Reis R, Frumowitz M, Milam M. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcome analysis. Gynecol Oncol. 2007;107:458-463. (Pubitemid 350160856)
21. Trimbos JB, Lambeek AF, Peters AAW, et al. Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer. Gynecol Oncol. 2004;95:77-81. (Pubitemid 39286280)
22. Sartori E, Tisi G, Chiudinelli F, et al. Early stage cervical cancer: adjuvant treatment in negative lymph node cases. Gynecol Oncol. 2007;107:S170-S174. (Pubitemid 47483866)
23. Zaino RJ, Ward S, Delgado G, et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. Cancer. 1992;69:1750-1758.
24. Havrilesky LJ, Leath CA, Huh W, et al. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. Gynecol Oncol. 2004;93:429-434. (Pubitemid 38507613)
25. Kamura T, Tsukamoto N, Tsuruchi N, et al. Histopathologic prognostic factors in stage IIb cervical carcinoma treated with radical hysterectomy and pelvic-node dissectionVan analysis with mathematical statistics. Int J Gynecol Cancer. 1993;3:219-225. (Pubitemid 23361860)
26. Horn LC, Fischer U, Raptis G, et al. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol. 2007;107:310-315. (Pubitemid 47575730)
27. Nakanishi T, Ishikawa H, Suzuki Y, et al. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2000;79:289-293.